Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Cocero Nanette | Director | 5 | $0 | $0 | 2025-09-17 |
| Dubin Gary | Director | 2 | $0 | $0 | 2025-09-17 |
| Sepulveda Jaime | Director | 5 | $0 | $0 | 2025-09-17 |
| Chu Shelley | Director | 5 | $0 | $0 | 2025-09-17 |
| Kohli Aditya | Director | 26 | $0 | $986.99M | 2025-09-17 |
| Maltbie Shane | Chief Financial Officer | 8 | $0 | $68.5K | 2025-09-17 |
| Gerberding Julie L. | Director | 5 | $0 | $0 | 2025-09-17 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | 1 | $0 | $0 | 2025-09-17 |
| Topper James N | 10% Owner | 5 | $30.00M | $0 | 2025-09-17 |
| HERSHBERG ROBERT | See Remarks | 8 | $0 | $221.7K | 2025-09-17 |
| HILLEMAN JERYL L | Director | 5 | $0 | $0 | 2025-09-17 |
| Heron Patrick J | Director, 10% Owner | 4 | $0 | $0 | 2025-06-23 |
| FHMLS X, L.P. | 10% Owner | 1 | $128.3K | $0 | 2024-04-04 |
| McLoughlin Sean | Chief Operating Officer | 2 | $21.2K | $0 | 2024-03-28 |
| Borkowski Astrid | Chief Medical Officer | 11 | $0 | $705.7K | 2024-02-08 |
| Takeda Vaccines, Inc. | 10% Owner | 2 | $0 | $0 | 2022-11-30 |
| Silbermann Susan Michele | Director | 1 | $0 | $0 | 2022-08-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Maltbie Shane | Chief Financial Officer | U Tender | 2025-09-17 | 2025-09-17 | 83,738 | — | $0 | 0 | SEC↗ |
| Gerberding Julie L. | Director | U Tender | 2025-09-17 | 2025-09-17 | 59,224 | — | $0 | 0 | SEC↗ |
| Dubin Gary | Director | U Tender | 2025-09-17 | 2025-09-17 | 17,199 | — | $0 | 0 | SEC↗ |
| Kohli Aditya | Director | U Tender | 2025-09-17 | 2025-09-17 | 698,171 | — | $0 | 0 | SEC↗ |
| HILLEMAN JERYL L | Director | U Tender | 2025-09-17 | 2025-09-17 | 59,224 | — | $0 | 0 | SEC↗ |
| Chu Shelley | Director | U Tender | 2025-09-17 | 2025-09-17 | 17,199 | — | $0 | 0 | SEC↗ |
| Cocero Nanette | Director | U Tender | 2025-09-17 | 2025-09-17 | 17,199 | — | $0 | 0 | SEC↗ |
| HERSHBERG ROBERT | President and CEO | U Tender | 2025-09-17 | 2025-09-17 | 1,101,498 | — | $0 | 0 | SEC↗ |
| Sepulveda Jaime | Director | U Tender | 2025-09-17 | 2025-09-17 | 59,224 | — | $0 | 0 | SEC↗ |
| Topper James N | 10% Owner | U Tender | 2025-09-17 | 2025-09-17 | 17,199 | $1.95 | $33.5K | 0 | SEC↗ |
| Topper James N | 10% Owner | U Tender | 2025-09-17 | 2025-09-17 | 8,535,337 | $1.95 | $16.64M | 0 | SEC↗ |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner | U Tender | 2025-09-17 | 2025-09-19 | 6,724,000 | $1.95 | $13.11M | 0 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 59,224 | SEC↗ |
| Dubin Gary | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 17,199 | SEC↗ |
| Gerberding Julie L. | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 59,224 | SEC↗ |
| Cocero Nanette | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 17,199 | SEC↗ |
| Sepulveda Jaime | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 59,224 | SEC↗ |
| Chu Shelley | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 17,199 | SEC↗ |
| Kohli Aditya | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 698,171 | SEC↗ |
| Heron Patrick J | Director | A Award | 2025-06-23 | 2025-06-25 | 17,199 | — | $0 | 17,199 | SEC↗ |
| Maltbie Shane | Chief Financial Officer | S Sale | 2025-02-11 | 2025-02-12 | 4,345 | $1.76 | $7.6K | 79,887 | SEC↗ |
| HERSHBERG ROBERT | See Remarks | S Sale | 2025-02-11 | 2025-02-12 | 11,901 | $1.76 | $20.9K | 1,101,498 | SEC↗ |
| Maltbie Shane | Chief Financial Officer | S Sale | 2025-02-04 | 2025-02-12 | 3,946 | $1.89 | $7.5K | 84,232 | SEC↗ |
| HERSHBERG ROBERT | See Remarks | S Sale | 2025-02-04 | 2025-02-12 | 14,634 | $1.89 | $27.7K | 1,113,399 | SEC↗ |
| Heron Patrick J | Director | A Award deriv | 2024-06-06 | 2025-04-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Sepulveda Jaime | Director | A Award deriv | 2024-06-06 | 2025-04-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award deriv | 2024-06-06 | 2025-04-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Gerberding Julie L. | Director | A Award deriv | 2024-06-06 | 2025-04-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Cocero Nanette | Director | A Award deriv | 2024-06-06 | 2025-04-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Chu Shelley | Director | A Award deriv | 2024-06-06 | 2025-04-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-05-22 | 2024-05-22 | 6,000 | $14.73 | $88.4K | 764,878 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-05-21 | 2024-05-22 | 6,000 | $14.21 | $85.3K | 770,878 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-05-20 | 2024-05-22 | 6,000 | $15.45 | $92.7K | 776,878 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-05-03 | 2024-05-03 | 723 | $14.15 | $10.2K | 782,878 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-05-02 | 2024-05-03 | 6,000 | $14.01 | $84.1K | 783,601 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-05-01 | 2024-05-03 | 175 | $14.03 | $2.5K | 789,601 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-04-05 | 2024-04-05 | 6,000 | $14.44 | $86.6K | 789,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-04-04 | 2024-04-05 | 6,000 | $14.71 | $88.3K | 795,776 | SEC↗ |
| FHMLS X, L.P. | 10% Owner | P Buy | 2024-04-04 | 2024-04-08 | 8,850 | $14.50 | $128.3K | 8,544,187 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-04-03 | 2024-04-05 | 6,000 | $14.93 | $89.6K | 801,776 | SEC↗ |
| McLoughlin Sean | Chief Operating Officer | P Buy | 2024-03-28 | 2024-04-01 | 1,250 | $16.98 | $21.2K | 1,250 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-03-20 | 2024-03-20 | 6,000 | $164221.00 | $985.33M | 807,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-03-19 | 2024-03-20 | 6,000 | $17.42 | $104.5K | 813,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-03-18 | 2024-03-20 | 6,000 | $17.66 | $106.0K | 819,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-03-08 | 2024-03-08 | 6,000 | $18.66 | $112.0K | 825,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-03-07 | 2024-03-08 | 6,000 | $18.37 | $110.2K | 831,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-03-06 | 2024-03-08 | 6,000 | $18.95 | $113.7K | 837,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-02-22 | 2024-02-22 | 6,000 | $15.05 | $90.3K | 843,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-02-21 | 2024-02-22 | 6,000 | $14.92 | $89.5K | 849,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-02-20 | 2024-02-22 | 6,000 | $14.88 | $89.3K | 855,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-02-12 | 2024-02-14 | 6,000 | $15.32 | $91.9K | 861,776 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | A Award deriv | 2024-02-08 | 2024-02-12 | 69,852 | — | $0 | 69,852 | SEC↗ |
| HERSHBERG ROBERT | See Remarks | A Award deriv | 2024-02-08 | 2024-02-12 | 226,885 | — | $0 | 226,885 | SEC↗ |
| Maltbie Shane | Chief Financial Officer | A Award deriv | 2024-02-08 | 2024-02-12 | 61,894 | — | $0 | 61,894 | SEC↗ |
| Kohli Aditya | Director | A Award deriv | 2024-02-08 | 2024-02-12 | 71,500 | — | $0 | 71,500 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | S Sale | 2024-02-08 | 2024-02-12 | 3,933 | $14.93 | $58.7K | 161,260 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | A Award | 2024-02-08 | 2024-02-12 | 53,632 | — | $0 | 214,892 | SEC↗ |
| HERSHBERG ROBERT | See Remarks | S Sale | 2024-02-08 | 2024-02-12 | 11,597 | $14.93 | $173.1K | 953,831 | SEC↗ |
| HERSHBERG ROBERT | See Remarks | A Award | 2024-02-08 | 2024-02-12 | 174,202 | — | $0 | 1,128,033 | SEC↗ |
| Maltbie Shane | Chief Financial Officer | S Sale | 2024-02-08 | 2024-02-12 | 3,576 | $14.93 | $53.4K | 40,656 | SEC↗ |
| Maltbie Shane | Chief Financial Officer | A Award | 2024-02-08 | 2024-02-12 | 47,522 | — | $0 | 88,178 | SEC↗ |
| Kohli Aditya | Director | A Award | 2024-02-08 | 2024-02-12 | 54,898 | — | $0 | 867,776 | SEC↗ |
| Kohli Aditya | Director | S Sale | 2024-02-08 | 2024-02-12 | 8,866 | $14.93 | $132.4K | 812,878 | SEC↗ |
| McLoughlin Sean | Chief Operating Officer | A Award deriv | 2024-01-31 | 2024-02-02 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | S Sale | 2023-12-15 | 2023-12-18 | 10,000 | $15.50 | $155.0K | 165,193 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | S Sale | 2023-12-04 | 2023-12-05 | 10,000 | $14.50 | $145.0K | 175,193 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | S Sale | 2023-12-01 | 2023-12-05 | 10,000 | $14.20 | $142.0K | 185,193 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | S Sale | 2023-11-17 | 2023-11-20 | 10,000 | $14.00 | $140.0K | 195,193 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | S Sale | 2023-11-08 | 2023-11-13 | 5,000 | $13.00 | $65.0K | 205,193 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | D To issuer | 2023-06-21 | 2023-06-23 | 10,000 | $16.11 | $161.1K | 210,193 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Sepulveda Jaime | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Gerberding Julie L. | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Cocero Nanette | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 11,000 | — | $0 | 11,000 | SEC↗ |
| Chu Shelley | Director | A Award deriv | 2023-06-07 | 2023-06-09 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Cocero Nanette | Director | A Award deriv | 2023-05-08 | 2023-05-10 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Maltbie Shane | Chief Financial Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 65,000 | — | $0 | 65,000 | SEC↗ |
| HERSHBERG ROBERT | President and CEO | A Award deriv | 2023-02-01 | 2023-02-03 | 381,950 | — | $0 | 381,950 | SEC↗ |
| Kohli Aditya | Chief Operating Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 128,200 | — | $0 | 128,200 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | A Award deriv | 2023-02-01 | 2023-02-03 | 77,000 | — | $0 | 77,000 | SEC↗ |
| Maltbie Shane | Chief Financial Officer | A Award | 2023-02-01 | 2023-02-03 | 43,333 | — | $0 | 44,232 | SEC↗ |
| HERSHBERG ROBERT | President and CEO | A Award | 2023-02-01 | 2023-02-03 | 187,966 | — | $0 | 965,428 | SEC↗ |
| Kohli Aditya | Chief Operating Officer | A Award | 2023-02-01 | 2023-02-03 | 85,466 | — | $0 | 821,744 | SEC↗ |
| Borkowski Astrid | Chief Medical Officer | A Award | 2023-02-01 | 2023-02-03 | 51,333 | — | $0 | 219,774 | SEC↗ |
| Takeda Vaccines, Inc. | 10% Owner | X Exercise deriv | 2022-11-30 | 2022-12-01 | 5,883,500 | — | $0 | 0 | SEC↗ |
| Takeda Vaccines, Inc. | 10% Owner | X Exercise | 2022-11-30 | 2022-12-01 | 5,883,500 | — | $0 | 6,724,000 | SEC↗ |
| Heron Patrick J | Director, 10% Owner | A Award deriv | 2022-08-19 | 2022-08-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Sepulveda Jaime | Director | A Award deriv | 2022-08-19 | 2022-08-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Chu Shelley | Director | A Award deriv | 2022-08-19 | 2022-08-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Gerberding Julie L. | Director | A Award deriv | 2022-08-19 | 2022-08-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| HILLEMAN JERYL L | Director | A Award deriv | 2022-08-19 | 2022-08-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Silbermann Susan Michele | Director | A Award deriv | 2022-08-19 | 2022-08-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Topper James N | 10% Owner | C Conversion deriv | 2022-05-03 | 2022-05-03 | 37,212,796 | — | $0 | 0 | SEC↗ |
| Topper James N | 10% Owner | P Buy | 2022-05-03 | 2022-05-03 | 1,764,706 | $17.00 | $30.00M | 8,535,337 | SEC↗ |
| Topper James N | 10% Owner | C Conversion | 2022-05-03 | 2022-05-03 | 2,736,234 | $13.60 | $37.21M | 6,770,631 | SEC↗ |